Free Trial
NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

Henry Schein logo
$65.17 -1.06 (-1.60%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$65.19 +0.02 (+0.03%)
As of 04/25/2025 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Henry Schein Stock (NASDAQ:HSIC)

Key Stats

Today's Range
$64.31
$66.10
50-Day Range
$62.70
$78.05
52-Week Range
$60.56
$82.49
Volume
736,945 shs
Average Volume
1.62 million shs
Market Capitalization
$7.98 billion
P/E Ratio
26.82
Dividend Yield
N/A
Price Target
$81.10
Consensus Rating
Moderate Buy

Company Overview

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Henry Schein Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
71st Percentile Overall Score

HSIC MarketRank™: 

Henry Schein scored higher than 71% of companies evaluated by MarketBeat, and ranked 133rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Henry Schein has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 5 buy ratings, 5 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Henry Schein has only been the subject of 3 research reports in the past 90 days.

  • Read more about Henry Schein's stock forecast and price target.
  • Earnings Growth

    Earnings for Henry Schein are expected to grow by 5.91% in the coming year, from $4.74 to $5.02 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Henry Schein is 26.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Henry Schein is 26.82, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.43.

  • Price to Earnings Growth Ratio

    Henry Schein has a PEG Ratio of 2.13. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Henry Schein has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Henry Schein's valuation and earnings.
  • Percentage of Shares Shorted

    4.72% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 0.20%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Henry Schein does not currently pay a dividend.

  • Dividend Growth

    Henry Schein does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.72% of the float of Henry Schein has been sold short.
  • Short Interest Ratio / Days to Cover

    Henry Schein has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Henry Schein has recently increased by 0.20%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Henry Schein has a news sentiment score of 1.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 23 news articles for Henry Schein this week, compared to 10 articles on an average week.
  • Search Interest

    Only 2 people have searched for HSIC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Henry Schein insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $472,150.00 in company stock.

  • Percentage Held by Insiders

    Only 1.14% of the stock of Henry Schein is held by insiders.

  • Percentage Held by Institutions

    96.62% of the stock of Henry Schein is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Henry Schein's insider trading history.
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Henry Schein (NASDAQ:HSIC) Downgraded by StockNews.com to Hold
Morgan Stanley Keeps Their Sell Rating on Henry Schein (HSIC)
See More Headlines

HSIC Stock Analysis - Frequently Asked Questions

Henry Schein's stock was trading at $69.20 at the beginning of the year. Since then, HSIC shares have decreased by 5.8% and is now trading at $65.17.
View the best growth stocks for 2025 here
.

Henry Schein, Inc. (NASDAQ:HSIC) released its earnings results on Tuesday, February, 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by $0.04. The firm's quarterly revenue was up 5.8% on a year-over-year basis.
Read the conference call transcript
.

Henry Schein's stock split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

The following companies are subsidiaries of Henry Schein: Prism Medical Products LLC, Elite Computer Italia, Southern Anesthesia & Surgical, Marrodent, Dental Cremer, RxWorks, Dental Trey, and others.

Henry Schein's top institutional shareholders include SG Americas Securities LLC (0.25%), Rhumbline Advisers (0.23%), GAMMA Investing LLC (0.22%) and Marathon Asset Management Ltd (0.19%). Insiders that own company stock include James P Breslawski, Stanley M Bergman, Gerald A Benjamin, Michael S Ettinger, Lorelei Mcglynn, Mark E Mlotek, David B Brous Jr, Bradford C Connett, Walter Siegel, Philip A Laskawy and Kurt P Kuehn.
View institutional ownership trends
.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Henry Schein investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR), AUO (AUOTY) and The RMR Group (RMR).

Company Calendar

Last Earnings
2/25/2025
Today
4/27/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
Employees
22,000
Year Founded
1932

Price Target and Rating

Average Stock Price Target
$81.10
High Stock Price Target
$90.00
Low Stock Price Target
$74.00
Potential Upside/Downside
+24.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.64
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
26.82
Forward P/E Ratio
13.75
P/E Growth
2.13
Net Income
$416 million
Pretax Margin
3.21%

Debt

Sales & Book Value

Annual Sales
$12.67 billion
Cash Flow
$5.58 per share
Price / Cash Flow
11.68
Book Value
$33.01 per share
Price / Book
1.97

Miscellaneous

Free Float
123,260,000
Market Cap
$7.98 billion
Optionable
Optionable
Beta
0.84

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:HSIC) was last updated on 4/27/2025 by MarketBeat.com Staff
From Our Partners